Topics
salmeterolChemical substance
formoterolChemical substance
Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potenc
AbstractWhile short-acting β2-agonists are seen as the cornerstone of treatment as relief medication...
In vitro data suggest that salmeterol, contrary to formoterol, can partly antagonise the effect of s...
In-vitro inhalation performance for formoterol dry powder and metred dose inhalers In-vitro characte...
Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of actio
SummaryRationaleFormoterol is approved as asthma rescue medication in many countries. The exact dura...
Inhaled β2-agonists are the most effective bronchodila-tors in current use and are the most widely p...
RATIONALE: Formoterol is approved as asthma rescue medication in many countries. The exact duration ...
Ten subjects with various degrees of asthma severity underwent a three-day trial, with the aim of ev...
Background Most of the currently available inhaled beta-2 agonists are short acting bronchodilators....
AbstractA double-blind, randomized crossover study in 28 asthmatic patients assessed the relative th...
The aim of the study was to investigate the time of onset and the duration of the bronchodilating ef...
AbstractA number of studies have already demonstrated the clinical effectiveness of formoterol when ...
Abstract Long-acting \uce\ub22-adrenoceptor agonists, formoterol and salmeterol, represent a milesto...
AbstractFormoterol and salmeterol are both long-acting bronchodilators that are effective in the tre...
IMPORTANCE OF THE FIELD: Asthma is a heterogeneous disease with various components that may contribu...
AbstractWhile short-acting β2-agonists are seen as the cornerstone of treatment as relief medication...
In vitro data suggest that salmeterol, contrary to formoterol, can partly antagonise the effect of s...
In-vitro inhalation performance for formoterol dry powder and metred dose inhalers In-vitro characte...
Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of actio
SummaryRationaleFormoterol is approved as asthma rescue medication in many countries. The exact dura...
Inhaled β2-agonists are the most effective bronchodila-tors in current use and are the most widely p...
RATIONALE: Formoterol is approved as asthma rescue medication in many countries. The exact duration ...
Ten subjects with various degrees of asthma severity underwent a three-day trial, with the aim of ev...
Background Most of the currently available inhaled beta-2 agonists are short acting bronchodilators....
AbstractA double-blind, randomized crossover study in 28 asthmatic patients assessed the relative th...
The aim of the study was to investigate the time of onset and the duration of the bronchodilating ef...
AbstractA number of studies have already demonstrated the clinical effectiveness of formoterol when ...
Abstract Long-acting \uce\ub22-adrenoceptor agonists, formoterol and salmeterol, represent a milesto...
AbstractFormoterol and salmeterol are both long-acting bronchodilators that are effective in the tre...
IMPORTANCE OF THE FIELD: Asthma is a heterogeneous disease with various components that may contribu...
AbstractWhile short-acting β2-agonists are seen as the cornerstone of treatment as relief medication...
In vitro data suggest that salmeterol, contrary to formoterol, can partly antagonise the effect of s...
In-vitro inhalation performance for formoterol dry powder and metred dose inhalers In-vitro characte...
Add to ORKG